Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial
抗程序性死亡配体1联合靶向治疗治疗间变性甲状腺癌:一项非随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2024.4729
Cabanillas, Maria E; Dadu, Ramona; Ferrarotto, Renata; Gule-Monroe, Maria; Liu, Suyu; Fellman, Bryan; Williams, Michelle D; Zafereo, Mark; Wang, Jennifer R; Lu, Charles; Ning, Matthew; McKinley, Brian A; Woodman, Scott E; Duose, Dzifa; Gunn, Gary B; Busaidy, Naifa L